Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Has announcements × Prostatic Neoplasms × Pluvicto × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

enzalutamide 2 apalutamide 2 Pluvicto 2 Leuprolide 2 Androgen Antagonists 2 relugolix 1 luprolide acetate gel depot 1 gallium 68 PSMA-11 1 Prednisone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04689828 2026-02-20

PSMAfore

Novartis

Phase 3 Active not recruiting

469 enrolled 11 charts 1 FDA

Prostatic Neoplasms

NCT03511664 2025-01-13

VISION

Endocyte

Phase 3 Completed

861 enrolled 39 charts 1 FDA

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡